Table 1 Summary of the characteristics of patients with double ALK fusions reported in previous case reports
Ref. | Study | Age | Gender | Smoking | ALK fusion variants | Response to crizotinib |
|---|---|---|---|---|---|---|
[13] | Xuan Wu, et al. 2020 | 32 | Male | Smoker | CCNY-ALK, and ATIC-ALK | Yes |
[14] | Xueqian Wu, et al. 2020 | 64 | Female | Non-smoker | NLRC4-ALK, and EML4‐ALK | Yes |
[15] | Jing Luo, et al. 2019 | 44 | Male | Smoker | PRKCB-ALK, and EML4-ALK | Yes |
[16] | Bao Dong Qin, et al. 2019 | 29 | Male | Smoker | EML4-ALK, and BCL11A-ALK | Yes |
[17] | Hao Lin, et al. 2018 | 56 | Male | Not available | EML6-ALK, and FBXO11-ALK | Yes |
[18] | Jinping Yin, et al. 2018 | 44 | Male | Smoker | DYSF-ALK, and ITGAV-ALK | Yes |